MPHM.F Stock Overview
Callitas Health Inc. provides over the counter consumer health and wellness products in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Callitas Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -99.91% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MPHM.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | n/a | 9.7% | 19.3% |
Return vs Industry: Insufficient data to determine how MPHM.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MPHM.F performed against the US Market.
Price Volatility
| MPHM.F volatility | |
|---|---|
| MPHM.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MPHM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MPHM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Brian Keane | callitas.com |
Callitas Health Inc. provides over the counter consumer health and wellness products in the United States and Canada. It offers C-103, a reformulation of Orlistat for the treatment of obesity; ToConceive, a fertility enhancing moisturizer; and Extrinsa for female sexual dysfunction solutions, as well as focuses on developing cannabinoid delivery technologies. The company was formerly known as M Pharmaceutical Inc. and changed its name to Callitas Health Inc. in September 2017.
Callitas Health Inc. Fundamentals Summary
| MPHM.F fundamental statistics | |
|---|---|
| Market cap | US$4.53k |
| Earnings (TTM) | -US$510.94k |
| Revenue (TTM) | US$495.33k |
0.0x
P/S Ratio0.0x
P/E RatioIs MPHM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPHM.F income statement (TTM) | |
|---|---|
| Revenue | CA$681.08k |
| Cost of Revenue | CA$337.28k |
| Gross Profit | CA$343.80k |
| Other Expenses | CA$1.05m |
| Earnings | -CA$702.54k |
Last Reported Earnings
Sep 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MPHM.F perform over the long term?
See historical performance and comparison